No Detail Found!

Management of Prediabetes.

Author(s)
Gagan Priya Department of Endocrinology, Fortis Hospital, Mohali, India
Abstract
Prediabetes is an intermediate stage of hyperglycaemia, characterized by impaired fasting glucose, impaired glucose tolerance and/ or an HbA1c ranging from 5.76.4%. Prediabetes is associated with an increased risk of progression to overt diabetes and increased risk of cardiovascular disease. Several intervention studies have demonstrated that onset of diabetes can be prevented or delayed with intensive lifestyle modification and oral antidiabetic agents including metformin, thiazolidinediones and alpha-glucosidase inhibitors. Prediabetes management should focus on lifestyle modification and multiple risk factor management. In cases at high risk, use of oral antidiabetic agents may be considered.
Publication Details
Page(s) 669-671
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Impaired glucose tolerance, Impaired fasting glucose, Diabetes prevention
References
Edwards CM, Cusi K. Prediabetes: a worldwide epidemic. Endocrinol Metab Clin N Am 2016; 45: 751-764 http://dx.doi.org/10.1016/j.ecl.2016.06.007
Ferrannini E. Definition of intervention points in prediabetes. Lancet Diabetes Endocrinol 2014; 2:667-75. doi:10.1016/S2213- 8587(13)70175-X.
GrundySM,,2012,Pre-diabetes, metabolic syndrome and cardiovascular risk,J Am Coll Cardiol,59,635,43
AmericanDiabetes,Association,,2017,Prevention or delay of type 2 diabetes,Diabetes Care,40,S008,S47
Garber AJ, Abrahamson MJ, Barzilay JI, Lawrence B, Zachary T. Bloomgarden et.al. (2016) Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary. Endocrine Practice: 2016; 22: 84-113.
Kanat M, DeFronzo R, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes 2015; 6: 1207-1222
Kerrison G, Gillis RB, Jiwani SI, Alzahrani Q, Kok S, Harding SE et.al. The effectiveness of lifestyle adaptation for the prevention of prediabetes in adults: a systematic review. Journal of Diabetes Research. 2017, DOI: 10.1155/2017/8493145
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 48:289-97. Epub 2006 Jan 4.
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, et.al. Diabetes Prevention Program Research Group. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/ Diabetes Prevention Program Outcomes Study. Diabetologia. 2017; doi: 10.1007/s00125-017- 4361-9.
GarveyWT,MechanickJI,BrettEM,GarberAJ,HurleyDL,JastreboffAM,,2016,American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity,Endocrine Practice: (Supplement 3),22,1,203
Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA. Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag 2014; 10: 173-88. doi:10.2147/TCRM.S39564.
0

Citations

0

Downloads

128

Views